Clinical Trial Update: Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update for an anti-IL-5 therapy in hypereosinophilic syndromes and related eosinophilic disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Churg-strauss Syndrome
• Eosinophilic Esophagitis
• Eosinophilic Gastroenteritis
• Hypereosinophilic Syndromes

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Hypereosinophilic Syndromes, Eosinophilic Gastroenteritis | Phase 1, Phase 2 | Status: COMPLETED